✦ LIBER ✦

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

✍ Scribed by R.B. Devereux; B. Dahlof; E. Gerdts

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Body Build and Risk of Cardiovascular Ev

✍ G. de Simone; K. Wachtell; V. Palmieri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Cost-effectiveness of losartan-based the

✍ McInnes, G; Burke, T A; Carides, G 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Crumbling of left ventricular hypertroph

✍ Franz H Messerli; Mandeep R Mehra 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Effects of losartan on cardiovascular mo

✍ S.E. Kjeldsen; B. Dahlor; R.B. Devereux 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Losartan benefits over atenolol in non-s

✍ Henrik M. Reims; Sverre E. Kjeldsen; Richard B. Devereux; Suzanne Oparil; Stevo 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 44 KB

An economic assessment of losartan-based

✍ Cornelis Boersma; George W. Carides; Jarir Atthobari; Adriaan A. Voors; Maarten 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 742 KB